Palisade Bio (PALI) Interest & Investment Income (2010 - 2021)
Palisade Bio (PALI) posted quarterly Interest & Investment Income of $3917.0 for Q1 2021, down 70.52% year-over-year from $13289.0 in Q1 2020, and down 30.02% quarter-over-quarter from $5597.0 in Q4 2020.
Palisade Bio (PALI) Interest & Investment Income (2010 - 2021) Analysis & Trends
Palisade Bio (PALI) has reported Interest & Investment Income for 12 consecutive years, with $3917.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Interest & Investment Income fell 70.52% year-over-year to $3917.0; the TTM figure through Mar 2021 stood at $24160.0 (down 53.56% YoY), while the FY2020 annual figure was $33532.0, down 50.49% from the prior year.
- Interest & Investment Income declined to $3917.0 in Q1 2021 per PALI's latest filing, from $5597.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $29000.0 in Q1 2019 and bottomed at $3917.0 in Q1 2021.
- Historically, Interest & Investment Income has averaged $14954.6 across 5 years, with a median of $15234.0 in 2019.
- Annual changes were most pronounced in 2017 — Interest & Investment Income jumped 87.53% — and 2021, when it sank 70.52%.
- Palisade Bio's Interest & Investment Income stood at $17274.0 in 2017, then surged by 38.35% to $23898.0 in 2018, then sank by 47.09% to $12645.0 in 2019, then plunged by 55.74% to $5597.0 in 2020, then tumbled by 30.02% to $3917.0 in 2021.
- Business Quant data shows PALI's Interest & Investment Income at $3917.0 in Q1 2021, $5597.0 in Q4 2020, and $7731.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 3,917.00 |
| Dec 31, 2020 | 5,597.00 |
| Sep 30, 2020 | 7,731.00 |
| Jun 30, 2020 | 6,915.00 |
| Mar 31, 2020 | 13,289.00 |
| Dec 31, 2019 | 12,645.00 |
| Sep 30, 2019 | 15,234.00 |
| Jun 30, 2019 | 10,852.00 |
| Mar 31, 2019 | 29,000.00 |
| Dec 31, 2018 | 23,898.00 |
| Sep 30, 2018 | 17,619.00 |
| Jun 30, 2018 | 19,514.00 |
| Mar 31, 2018 | 17,749.00 |
| Dec 31, 2017 | 17,274.00 |
| Sep 30, 2017 | 18,099.00 |
| Jun 30, 2017 | 14,013.00 |
| Mar 31, 2017 | 20,883.00 |
| Dec 31, 2016 | 16,973.00 |
| Sep 30, 2016 | 17,293.00 |
| Jun 30, 2016 | 13,433.00 |